CyPHR represents a major advancement in the application of pharmacogenomics, bridging the gap between genetic insight ...
Faculty in the Statistics in Genomics and Genetics Hub develop statistical and computational methods for analyzing high-throughput genomic and epigenomic data to advance biological discovery in cancer ...
GSK and Genomics plc will collaborate on a new precision medicine initiative that assesses how genetic data can be used in clinical trial design, Genomics announced April 30. The project will look at ...
BALTIMORE, March 12, 2026 /PRNewswire/ -- Genomics, a science-led techbio company using large-scale genetic information to develop innovative precision healthcare tools and to accelerate drug ...
Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among ...
In genome-wide association studies (GWAS), researchers look for small variations in the sequences of human genes that are connected to some characteristic or condition. Scientists have now performed ...
The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...
Merck & Co. will apply the somatic genomics platform Quotient Therapeutics to discover novel drug targets in inflammatory bowel disease (IBD), through a collaboration that could generate up to $2.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results